Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2012 May 1;20(5):1076. doi: 10.1038/mt.2011.300

Corrigendum: Discovery of a Linear Peptide for Improving Tumor Targeting of Gene Products and Treatment of Distal Tumors by IL-12 Gene Therapy

PMCID: PMC3345976  PMID: 28160622

Jeffry Cutrera, Denada Dibra, Xueqing Xia, Azeem Hasan, Scott Reed and Shulin Li

Molecular Therapy (2011) 19 (8): 1468–1477; doi:10.1038/mt.2011.38

Following the publication of this article, the authors noted errors in Figure 1. The xenogeneic tumor model (the first section of the Results, the second section of the Methods, and Figure 1) is errantly described as the xenogeneic human breast carcinoma cell line MCF7; however, the xenogeneic human tumor model used in these experiments was HT29, a human colon cancer cell line. The revised figure appears below:

Figure 1.

Figure 1


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES